Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Millennials are the most likely group to say they're planning to switch to an alternative like Compounded* Liraglutide with B12 (46%)
Key safety findings include: No established LD50: Researchers haven't been able to determine a lethal dose in animal models, even at doses many times higher than therapeutic ranges No observed organ toxicity: Studies examining the effects of BPC-157 on liver, kidney, heart, and other organs haven't shown toxic effects No hormonal disruption: Unlike many compounds used for recovery and healing (such as growth hormone secretagogues or anabolic agents), BPC-157 doesn't appear to alter endocrine function No tumor promotion: Studies conducted to date haven't shown that BPC-157 promotes tumor growth or increases cancer risk, though this is an area that warrants continued monitoring Stable across administration routes: Both oral and injectable BPC-157 have shown comparable safety profiles Reported Side Effects Based on clinical observations and user reports, the side effects of BPC-157 are generally mild and self-limiting: Common Side Effects (Mild, Transient) Injection site reactions: Mild redness, minor swelling, or slight discomfort at the injection site
Funding This work was supported by grants from the National Natural Science Foundation of China (U21A20364) and National Key Research and Development Project of China (2024YFC3308400)
Should you file an Ozempic, Wegovy, or GLP-1 lawsuit
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
US$ 22.38
US$ 20.86
US$ 25.01
US$ 25.17
US$ 24.41
US$ 29.42
US$ 29.74
